Clarinex-D 12 Hour

Physicians Total Care, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 30, 2009
Approval ID: c7230a68-a3ac-4dce-9e72-6e21f0b25f45
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CLARINEX-D 12 HOUR Extended Release Tablets safely and effectively. See full prescribing information for CLARINEX-D 12 HOUR Extended Release Tablets. CLARINEX-D 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use. Initial U.S. Approval: 2005

Quick Stats

Total Products1

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.